TRANSCRIPTA

Serial Number 98569148
Registration 7729649
700

Registration Progress

Application Filed
May 25, 2024
Under Examination
Approved for Publication
Jan 28, 2025
Published for Opposition
Jan 28, 2025
Registered
Mar 18, 2025

Trademark Image

TRANSCRIPTA

Basic Information

Serial Number
98569148
Registration Number
7729649
Filing Date
May 25, 2024
Registration Date
March 18, 2025
Published for Opposition
January 28, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 18, 2025
Registration
Registered
Classes
042

Rights Holder

Transcripta Bio, Inc.

03
Address
1804 Embarcadero Road
Suite 201
Palo Alto, CA 94303

Ownership History

Transcripta Bio, Inc.

Original Applicant
03
Palo Alto, CA

Transcripta Bio, Inc.

Owner at Publication
03
Palo Alto, CA

Transcripta Bio, Inc.

Original Registrant
03
Palo Alto, CA

Legal Representation

Attorney
Anne H. Peck

USPTO Deadlines

Next Deadline
2056 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-03-18)
Due Date
March 18, 2031
Grace Period Ends
September 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Mar 18, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Mar 18, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 28, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 28, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 22, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 2, 2025 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Jan 2, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 27, 2024 ALIE A ASSIGNED TO LIE Loading...
Dec 20, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 20, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 20, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 20, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 20, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 20, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 19, 2024 CORV P REVIEW OF CORRESPONDENCE COMPLETE Loading...
Dec 19, 2024 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Dec 19, 2024 ATRV O ATTORNEY REVIEW COMPLETED Loading...
Dec 19, 2024 AMPX O PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Loading...
Dec 18, 2024 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 18, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 18, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 18, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 10, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 10, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 10, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 3, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 7, 2024 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Nov 7, 2024 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
May 25, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Scientific, biotechnology, and medical research and development services; medical testing services, namely, blood, cell and/or tissue sample preparation and testing; developing potential therapies and interventions in the field of rare diseases, namely, development of pharmaceutical compounds, cell- and gene therapies, antibodies, personalized medicine, drug repurposing; performing medical nonclinical and clinical research in the field of rare diseases
First Use Anywhere: 20240400
First Use in Commerce: 20240400

Classification

International Classes
042